Biallelic ZNFX1 variants are associated with a spectrum of immuno-hematological abnormalities.


Journal

Clinical genetics
ISSN: 1399-0004
Titre abrégé: Clin Genet
Pays: Denmark
ID NLM: 0253664

Informations de publication

Date de publication:
02 2022
Historique:
revised: 08 09 2021
received: 28 06 2021
accepted: 23 10 2021
pubmed: 29 10 2021
medline: 29 3 2022
entrez: 28 10 2021
Statut: ppublish

Résumé

Biallelic changes in the ZNFX1 gene have been recently reported to cause severe familial immunodeficiency. Through a search of our bio/databank with information from genetic testing of >55 000 individuals, we identified nine additional patients from seven families with six novel homozygous ZNFX1 variants. Consistent with the previously described phenotype, our patients suffered from monocytosis, thrombocytopenia, hepatosplenomegaly, recurrent infections, and lymphadenopathy. The two most severely affected probands also had renal involvement and clinical presentations compatible with hemophagocytic lymphohistiocytosis. The disease was less lethal among our patients than previously reported. We identified two missense changes, two variants predicted to result in complete protein loss through nonsense-mediated decay, and two frameshift changes that likely introduce a truncation. Our findings (i) independently confirm the role of ZNFX1 in primary genetic immunodeficiency, (ii) expand the genetic and clinical spectrum of ZNFX1-related disease, and (iii) illustrate the utility of large, well-curated, and continually updated genotype-phenotype databases in resolving molecular diagnoses of patients with initially negative genetic testing findings.

Identifiants

pubmed: 34708404
doi: 10.1111/cge.14081
doi:

Substances chimiques

Antigens, Neoplasm 0
ZNFX1 protein, human 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

247-254

Informations de copyright

© 2021 John Wiley & Sons A/S . Published by John Wiley & Sons Ltd.

Références

Schneider WM, Chevillotte MD, Rice CM. Interferon-stimulated genes: a complex web of host defenses. Annu Rev Immunol. 2014;32:513-545. doi:10.1146/annurev-immunol-032713-120231
Alphonse N, Dickenson RE, Odendall C. Interferons: tug of war between bacteria and their host. Front Cell Infect Microbiol. 2021;11:10. doi:10.3389/fcimb.2021.624094
Le Voyer T, Neehus A-L, Yang R, et al. Inherited deficiency of stress granule ZNFX1 in patients with monocytosis and mycobacterial disease. Proc Natl Acad Sci. 2021;118(15):e2102804118. doi:10.1073/pnas.2102804118
Vavassori S, Chou J, Faletti LE, et al. Multisystem inflammation and susceptibility to viral infections in human ZNFX1 deficiency. J Allergy Clin Immunol. 2021;148:381-393. doi:10.1016/j.jaci.2021.03.045
Trujillano D, Oprea G-E, Schmitz Y, Bertoli-Avella AM, Abou Jamra R, Rolfs A. A comprehensive global genotype-phenotype database for rare diseases. Mol Genet Genomic Med. 2017;5(1):66-75. doi:10.1002/mgg3.262
Trujillano D, Bertoli-Avella AM, Kumar Kandaswamy K, et al. Clinical exome sequencing: results from 2819 samples reflecting 1000 families. Eur J Hum Genet. 2017;25(2):176-182. doi:10.1038/ejhg.2016.146
Bauer P, Kandaswamy KK, Weiss MER, et al. Development of an evidence-based algorithm that optimizes sensitivity and specificity in ES-based diagnostics of a clinically heterogeneous patient population. Genet Med. 2019;21(1):53-61. doi:10.1038/s41436-018-0016-6
Fairman-Williams ME, Guenther UP, Jankowsky E. SF1 and SF2 helicases: family matters. Curr Opin Struct Biol. 2010;20(3):313-324. doi:10.1016/j.sbi.2010.03.011
Wang Y, Yuan S, Jia X, et al. Mitochondria-localised ZNFX1 functions as a dsRNA sensor to initiate antiviral responses through MAVS. Nat Cell Biol. 2019;21(11):1346-1356. doi:10.1038/s41556-019-0416-0
Lindeboom RGH, Supek F, Lehner B. The rules and impact of nonsense-mediated mRNA decay in human cancers. Nat Genet. 2016;48(10):1112-1118. doi:10.1038/ng.3664
Neu-Yilik G, Amthor B, Gehring NH, et al. Mechanism of escape from nonsense-mediated mRNA decay of human β-globin transcripts with nonsense mutations in the first exon. RNA. 2011;17(5):843-854. doi:10.1261/rna.2401811

Auteurs

Salem Alawbathani (S)

Genomic Research & Medical Reporting, CENTOGENE GmbH, Rostock, Germany.

Ana Westenberger (A)

Genomic Research & Medical Reporting, CENTOGENE GmbH, Rostock, Germany.
Institute of Neurogenetics, University of Lübeck, Lübeck, Germany.

Natalia Ordonez-Herrera (N)

Genomic Research & Medical Reporting, CENTOGENE GmbH, Rostock, Germany.

Mariam Al-Hilali (M)

Department of Pediatrics, Prince Sultan Military Medical City, Riyadh, Saudi Arabia.

Homoud Al Hebby (H)

Department of Pediatrics, Prince Sultan Military Medical City, Riyadh, Saudi Arabia.

Fahad Alabbas (F)

Department of Pediatrics, Prince Sultan Military Medical City, Riyadh, Saudi Arabia.

Amal M Alhashem (AM)

Division of Pediatric Genetics, Department of Pediatrics, Prince Sultan Military Medical City, Riyadh, Saudi Arabia.

Ghaleb Elyamany (G)

Department of Pediatrics, Prince Sultan Military Medical City, Riyadh, Saudi Arabia.

André Megarbane (A)

Department of Human Genetics, Gilbert and Rose-Marie Chagoury School of Medicine, Lebanese American University, Beirut, Lebanon.
Division of Medical Genetics, Institut Jerome Lejeune, Paris, France.

Melis Kose (M)

Department of Pediatrics, Division of Inborn Errors of Metabolism, Izmir Katip Çelebi University Medical Faculty, Izmir, Turkey.
Ege University Medical Faculty, Department of Pediatrics, Division of Genetics, Izmir, Turkey.

Nadia Alhashmi (N)

Clinical and Biochemical Genetics Department, Child Health Department, Royal Hospital, Muscat, Oman.

Nashat Al Sukaiti (N)

Allergy and Clinical Immunology Department, Child Health Department, Royal Hospital, Muscat, Oman.

Mohammed Al-Raqad (M)

Al-Balqa Applied University, Faculty of Medicine, Al-Salt, Jordan.

Samah Al-Tawalbeh (S)

Queen Rania Al-Abdulla Children Hospital, King Hussein Medical Center, Amman, Jordan.

Omar Abu Adas Blanco (O)

Clinical Genetics department, The Genome Outpost, Amman, Jordan.

Fadiah Alkhattabi (F)

College of Medicine at Alfaisal University, King Faisal Specialist Hospital & Research Centre, Riyadh, Saudi Arabia.

Danielle Sng (D)

Laboratory of Human Genetics and Therapeutics, Genome Institute of Singapore, A*STAR, Singapore.

Ruslan Al-Ali (R)

Genomic Research & Medical Reporting, CENTOGENE GmbH, Rostock, Germany.

Suliman Khan (S)

Genomic Research & Medical Reporting, CENTOGENE GmbH, Rostock, Germany.

Hasan Tawamie (H)

Genomic Research & Medical Reporting, CENTOGENE GmbH, Rostock, Germany.

Kornelia Tripolszki (K)

Genomic Research & Medical Reporting, CENTOGENE GmbH, Rostock, Germany.

Vasiliki Karageorgou (V)

Genomic Research & Medical Reporting, CENTOGENE GmbH, Rostock, Germany.

Roberta Trunzo (R)

Genomic Research & Medical Reporting, CENTOGENE GmbH, Rostock, Germany.

Fuad Al Mutairi (F)

King Abdullah International Medical Research Center, King Saud bin Abdulaziz University for Health Sciences, MNGHA, Riyadh, Saudi Arabia.
Genetics & Precision Medicine Department, King Abdullah Specialized Children Hospital, King Abdulaziz Medical City, MNGHA, Riyadh, Saudi Arabia.

Bruno Reversade (B)

Laboratory of Human Genetics and Therapeutics, Genome Institute of Singapore, A*STAR, Singapore.

Peter Bauer (P)

Genomic Research & Medical Reporting, CENTOGENE GmbH, Rostock, Germany.

Aida M Bertoli-Avella (AM)

Genomic Research & Medical Reporting, CENTOGENE GmbH, Rostock, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH